| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/29/2000 | US6110498 A wicking agent which provides enhanced flow channels for the drug and which has been made into its solubilized form by solubilizer, while still within the tablet, thus, the drug is delivered out through passages in the coating wall by osmosis |
| 08/29/2000 | US6110497 Pharmaceutical formulations |
| 08/29/2000 | US6110495 A controlled release of nicotine and flavor additives from a smokeless nicotine stimulation can be obtained by a saliva soluble stimulant comprising a gel formed by gelation of water binding gel, nicotine or other alkaloids |
| 08/29/2000 | US6110494 The mini-tablets which release cisapride or its salt in a controlled manner in the distal regions of gastrointestinal tract have a core of cisapride or a salt embedded in a hydrophilic polymer coated with a ph dependent polymer |
| 08/29/2000 | US6110493 Terazosin capsules |
| 08/29/2000 | US6110492 Immunogenic compositions |
| 08/29/2000 | US6110491 Compound-loaded liposomes and methods for their preparation |
| 08/29/2000 | US6110490 Comprising a multilayer membrane surrounding an internal aqueous liposome comprising atleast one cationic lipopolyamine and one neutral lipid |
| 08/29/2000 | US6110488 Applying a polymeric acrylic pressure sensitive adhesive to a detacable protective layer, applying absorbent factric to the adhesive, applying a drug and laminating a backing layer to the fabric material |
| 08/29/2000 | US6110487 Method of making porous keratin scaffolds and products of same |
| 08/29/2000 | US6110486 Buccal polar spray or capsule |
| 08/29/2000 | US6110485 Includes a therapeutical agent and retanoid along with a carrier sized for insertion into eye tissue in which the systemic release of a therapeutical agent is desired for providing sustained or controlled release of the drug |
| 08/29/2000 | US6110481 A controlled release dispenser employing microporous membranes with or without a nonporous coating and aqueous-organic partitioning of the bioreactive substances such as pesticides, hormones, nutrients and fragrances to humans or animals |
| 08/29/2000 | US6110478 Oral carotenoid of carotene compounds |
| 08/29/2000 | US6110473 Sustained release emulsions with gels and anionic hydrocolloids |
| 08/29/2000 | US6110471 Administering phosphodiesterase for inhibition of the cycles |
| 08/29/2000 | US6110444 Dispersion free microbubbles of water insoluble gas |
| 08/29/2000 | US6110443 Dissolving in water and ultrasonic imaging and microbubble with surfactants of phospholipid and stabilizers |
| 08/29/2000 | US6109905 Apparatus for granulating powder |
| 08/29/2000 | CA2065210C Controlled release matrix for pharmaceuticals |
| 08/25/2000 | CA2263042A1 Treatment of edema |
| 08/24/2000 | WO2000049135A2 Substrate for cell growth |
| 08/24/2000 | WO2000049030A1 5-fluorouridine derivatives and anticancer agents containing the same as the active ingredient |
| 08/24/2000 | WO2000048660A1 Implant |
| 08/24/2000 | WO2000048643A1 Biodegradable, injectable oligomer-polymer composition |
| 08/24/2000 | WO2000048642A2 Biocompatible material with a novel functionality |
| 08/24/2000 | WO2000048637A1 Painless and tissue-conserving injection of medicaments |
| 08/24/2000 | WO2000048636A1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 08/24/2000 | WO2000048635A1 Novel albumin-free factor viii formulations |
| 08/24/2000 | WO2000048634A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048626A2 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease |
| 08/24/2000 | WO2000048611A1 Liposome preparations containing antitumor drug |
| 08/24/2000 | WO2000048608A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb¿1? |
| 08/24/2000 | WO2000048607A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 08/24/2000 | WO2000048599A1 Use of desoxypeganine in the treatment of alzheimer's dementia |
| 08/24/2000 | WO2000048598A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/24/2000 | WO2000048596A1 Soluble forms of amoxicillin and treatment of animals |
| 08/24/2000 | WO2000048589A1 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
| 08/24/2000 | WO2000048588A1 Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug |
| 08/24/2000 | WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma |
| 08/24/2000 | WO2000048585A1 Effervescent laxatives |
| 08/24/2000 | WO2000048582A2 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |
| 08/24/2000 | WO2000048580A1 Sheet-form adhesive preparation |
| 08/24/2000 | WO2000048579A1 Desoxypeganine transdermal therapeutic system |
| 08/24/2000 | WO2000048578A1 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same |
| 08/24/2000 | WO2000048577A1 Medicament for the treatment and prevention of cancer of the intestine |
| 08/24/2000 | WO2000048576A1 Stereocomplex hydrogels |
| 08/24/2000 | WO2000048575A1 Tablets and process for producing tablets |
| 08/24/2000 | WO2000048574A1 Elegant film coating system |
| 08/24/2000 | WO2000048573A1 Biodegradable composite material for the production of microcapsules |
| 08/24/2000 | WO2000048572A1 Phosphocholine linked prodrug derivatives |
| 08/24/2000 | WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 08/24/2000 | WO2000048570A1 Pharmaceutical composition for balanic transmucosal administration of alfuzosin |
| 08/24/2000 | WO2000048567A1 Method and composition for treating acne |
| 08/24/2000 | WO2000048566A1 Skin preparations for external use |
| 08/24/2000 | WO2000048551A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 08/24/2000 | WO2000048541A1 Zinc chloride in treating skin diseases |
| 08/24/2000 | WO2000025745A3 Irrigation solution and method for inhibition of pain and inflammation |
| 08/24/2000 | WO2000025743A3 Improved growth stimulant compositions |
| 08/24/2000 | WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
| 08/24/2000 | WO2000016818A9 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same |
| 08/24/2000 | WO2000013673A8 Extended release acetaminophen |
| 08/24/2000 | WO2000010536A9 Extended release buccal bioadhesive tablet |
| 08/24/2000 | WO2000006194A3 Depletion of cells responsible for antibody-mediated graft rejection |
| 08/24/2000 | WO1999066900A3 Use of nonoxynol-9 as lubricant and method for its production |
| 08/24/2000 | WO1999065540A3 Medical infusion device with a source of controlled compliance |
| 08/24/2000 | DE19948783A1 Implant useful for sustained drug release comprises a drug-containing chamber having at least one porous exit port permitting drug diffusion without free flow through the chamber |
| 08/24/2000 | DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs |
| 08/24/2000 | DE19907878A1 Preparing medicaments and nutritional supplement compositions suitable for individual subjects, by determining the necessary active agents using Is/Should Be analysis |
| 08/24/2000 | DE19906978A1 Treating drug dependence and/or addiction, e.g. due to cocaine or heroin, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor which crosses blood-brain barrier |
| 08/24/2000 | DE19906975A1 Treating Alzheimer's dementia, especially by improving cognitive ability, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor |
| 08/24/2000 | DE10008880A1 Biodegradable polymer conjugates for microencapsulating solid or dissolved substances in organic solvents or aqueous emulsions include an enzymatic cleavage site |
| 08/24/2000 | CA2634674A1 Novel albumin-free factor viii formulations |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371800A1 Implant |
| 08/24/2000 | CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma |
| 08/24/2000 | CA2362356A1 Elegant film coating system |
| 08/24/2000 | CA2362355A1 Effervescent laxatives |
| 08/24/2000 | CA2362346A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 08/24/2000 | CA2362293A1 Tablet and tablet production method |
| 08/24/2000 | CA2362263A1 Biodegradable composite material for the production of microcapsules |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2299117A1 Antimycotic compositions |
| 08/23/2000 | EP1029892A1 Freeze-dried polysaccharide-especially paramylon containing agent, its preparation and use |
| 08/23/2000 | EP1029587A1 Nanocapsules based on poly(alkylene adipate), their fabrication process, cosmetic and dermatological compositions containing them |
| 08/23/2000 | EP1029586A2 Emulsifiers |
| 08/23/2000 | EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 08/23/2000 | EP1029545A2 Composition for oral administration of nutritional supplement or medicaments in tablet form |
| 08/23/2000 | EP1029544A1 Intra-cancer-cell nuclease activator |
| 08/23/2000 | EP1029543A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/23/2000 | EP1029542A1 Percutaneously absorbable preparation |
| 08/23/2000 | EP1029539A1 Pharmaceutical filled hard capsules |
| 08/23/2000 | EP1029538A2 Soft gelatin capsule manufacture |
| 08/23/2000 | EP1029537A1 Sustained release eyedrops |
| 08/23/2000 | EP1029536A1 Buccal non-polar spray |
| 08/23/2000 | EP1029070A1 Transfecting peptide vector, composition containing same and applications |
| 08/23/2000 | EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 08/23/2000 | EP1028991A1 Strictly alternating poly(alkylene oxide ether) copolymers |